A new pathway to treat PAH targeted by the first activin signaling inhibitor (ASI)

31 August 2025 (15:23 - 15:31)
Organised by: Logo
Congress Presentation Part of: A new way to treat pulmonary arterial hypertension (PAH) that improves hemodynamics and right ventricular function Treatment Open Access ESC Congress 2025 European Society of Cardiology